Acadian Asset Management
TNGX icon

Acadian Asset Management’s Tango Therapeutics TNGX Stock Holding History

Acadian Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-81,953
Closed -$419K – 2007
2025
Q2 		$419K Sell
81,953
-891,356
-92% -$2.2M ﹤0.01% 1174
2025
Q1 		$1.33M Buy
973,309
+478,203
+97% +$1.17M ﹤0.01% 862
2024
Q4 		$1.53M Buy
+495,106
New +$2.3M ﹤0.01% 837

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management's TNGX Position: Q3 2025 in Review

Acadian Asset Management sold out of Tango Therapeutics (TNGX) in Q3 2025, closing a stake of 81,953 shares — an estimated $419K sold.

Acadian Asset Management first reported a position in TNGX in Q4 2024 and held it in 3 quarters. The position peaked at $1.53M in Q4 2024. 141 funds tracked by Wall St. Rank hold TNGX as of Q3 2025.

  • Acadian Asset Management reported no remaining Tango Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Acadian Asset Management sold 81,953 Tango Therapeutics shares in Q3 2025, an estimated $419K.
  • Acadian Asset Management first reported a position in Tango Therapeutics in Q4 2024 and held it in 3 quarters.
  • Acadian Asset Management's Tango Therapeutics position peaked at $1.53M in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2025.

Based on Acadian Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.